Five details:
1. AdventHealth partnered with Berg, a clinical-state biotech company, to develop the patient registry.
2. The biobank registry will include comprehensive EHR records for patients who test positive for AdventHealth COVID-19, including hospital length of stay, medications and outcomes.
3. Using the Berg AI platform, AdventHealth will monitor clinical data to understand which health factors increase the risk for COVID-19 illness.
4. Eventually, the partners aim to include enterprisewide data to conduct an exploratory analysis of chronically administered medications associated with better outcomes and lower SARS-CoV-2 infection rates.
5. The partners will use the framework created in their precision medicine partnership to improve outcomes for non-alcoholic fatty liver disease and sarcopenia.
More articles on health IT:
Northwell AI tool allows nurses to strategically monitor overnight vitals
Mount Sinai builds machine learning models to predict COVID-19 mortality
Google launches AI tools for healthcare to streamline document review, analysis
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
